Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001193125-26-418094

Chief Financial Officer sold 17,717 shares at an average $18.59 ($329,322)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Catinazzo Thomas · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-06 Sale : show line 1 in the form 10b5-1 −17,511 $18.58 $325,354 105,340 D
2026-10-06 Sale : show line 2 in the form 10b5-1 −206 $19.26 $3,968 105,134 D
Open-market sales · 17,717 sh · avg $18.59 · $329,322
Loading xslF345X06/ownership.xml…